(CNN) - Patients in the United States can now get the popular diabetes and weight loss drug Ozempic for half the price. Novo ...

Women between the ages of 50 and 64 use medications the most. Nearly 12% of people in the United States have taken GLP-1 medications for weight loss, with usage especially common among women ages 50 ...

Novo Nordisk announced Monday that US patients can now get a month’s supply of Ozempic, the blockbuster diabetes drug, for ...

Longer-term studies will be needed to track whether per-patient costs might drop over time with continued use of the meds.

NAION is a rare form of vision loss that’s been linked to semaglutide, the active ingredient in Wegovy and Ozempic.

According to NPR, doctors and patients alike have noted the drug has appeared to reduce some people's cravings for booze, ...

GLP-1 drugs suppress appetite and have been shown to reduce calorie intake by up to 800 calories per person per day. GLP-1 ...

Eli Lilly & Novo Nordisk target cash-pay customers in the GLP-1 weight loss market with $499 monthly offers. Read more here.

Using GLP-1 drugs for weight loss is considered safe but can come with a loss of lean muscle mass. It’s crucial to do ...

Most people have likely heard about the new weight-loss and diabetes management drugs called Ozempic and Mounjaro, which are ...

Studies have linked GLP-1 medications to various eye conditions, some of which may lead to vision loss. Despite these ...

The Trump administration is considering a shift in health care coverage, allowing Medicare and Medicaid to cover GLP-1 weight loss drugs.